-
Je něco špatně v tomto záznamu ?
Effect of Schiff base Cu(II) complexes on signaling pathways in HT-29 cells
K. Koňariková, GA. Perdikaris, H. Gbelcova, L. Andrezálová, M. Švéda, T. Ruml, L. Laubertová, I. Žitňanová,
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2008 do Před 1 rokem
Freely Accessible Science Journals
od 2008
ProQuest Central
od 2012-01-01
Health & Medicine (ProQuest)
od 2012-01-01
PubMed
27633628
DOI
10.3892/mmr.2016.5739
Knihovny.cz E-zdroje
- MeSH
- apoptóza účinky léků MeSH
- buňky HT-29 MeSH
- lidé MeSH
- měď aplikace a dávkování MeSH
- mitochondrie účinky léků MeSH
- myši MeSH
- nádorové proteiny biosyntéza MeSH
- nádory tračníku farmakoterapie patologie MeSH
- proliferace buněk účinky léků MeSH
- protinádorové látky aplikace a dávkování MeSH
- regulace genové exprese u nádorů účinky léků MeSH
- Schiffovy báze aplikace a dávkování MeSH
- signální transdukce účinky léků MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Schiff base copper (II) complexes are known for their anticancer, antifungal, antiviral and anti‑inflammatory activities. The aim of the current study was to investigate biological effects of Schiff base Cu (II) complexes (0.001‑100 µmol/l)‑[Cu2(sal‑D, L‑glu)2(isoquinoline)2]·2C2H5OH (1), [Cu(sal‑5‑met‑L‑glu)(H2O)].H2O (2), [Cu(ethanol)2(imidazole)4][Cu2(sal‑D, L-glu)2(imidazole)2] (3), [Cu(sal‑D,L‑glu)(2‑methylimidazole)] (4) on the human colon carcinoma cells HT‑29, the mouse noncancerous cell line NIH‑3T3 and the human noncancerous fibroblast cell line VH10. The results suggested that Cu (II) complexes exhibit cytotoxic effects against the HT‑29 cell line, while complexes 3 and 4 were the most effective. Subsequent to 72 h of incubation, apoptosis was observed in the HT‑29 cells induced by Cu (II) complexes 1 (0.1, 1, 10 and 50 µmol/l), 2 (1, 10, 50 and 100 µmol/l), 3 (0.01, 1, 10 and 50 µmol/l) and 4 (0.01, 0.1, 1 and 10 µmol/l). The apoptotic pathways activated by the Cu (II) complexes were identified. The results indicated that complexes 2, 3 and 4 were able to induce the mitochondria‑dependent pathway of apoptosis in HT‑29 cells, while complex 1 was obsered to activate the extrinsic pathway of apoptosis. The levels of the anti‑apoptotic protein Bcl‑2 were reduced and those of the pro‑apoptotic protein Bax increased following treatment with complexes 2, 3 and 4. Complex 1 had no effect on Bax protein expression. Complexes 2 and 3 induced elevation of cytochrome c (cyt c), while complex 4 induced a time‑dependent elevation of cyt c levels. No cyt c was detected in HT‑29 cells exposed to complex 1, suggesting that Cu (II) complexes activated the extrinsic pathway of apoptosis. The results from the current study in addition to previous studies suggest that Schiff base Cu (II) complexes have potential as novel anticancer drugs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023585
- 003
- CZ-PrNML
- 005
- 20170908104650.0
- 007
- ta
- 008
- 170720s2016 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/mmr.2016.5739 $2 doi
- 035 __
- $a (PubMed)27633628
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Koňariková, Katarína $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovak Republic.
- 245 10
- $a Effect of Schiff base Cu(II) complexes on signaling pathways in HT-29 cells / $c K. Koňariková, GA. Perdikaris, H. Gbelcova, L. Andrezálová, M. Švéda, T. Ruml, L. Laubertová, I. Žitňanová,
- 520 9_
- $a Schiff base copper (II) complexes are known for their anticancer, antifungal, antiviral and anti‑inflammatory activities. The aim of the current study was to investigate biological effects of Schiff base Cu (II) complexes (0.001‑100 µmol/l)‑[Cu2(sal‑D, L‑glu)2(isoquinoline)2]·2C2H5OH (1), [Cu(sal‑5‑met‑L‑glu)(H2O)].H2O (2), [Cu(ethanol)2(imidazole)4][Cu2(sal‑D, L-glu)2(imidazole)2] (3), [Cu(sal‑D,L‑glu)(2‑methylimidazole)] (4) on the human colon carcinoma cells HT‑29, the mouse noncancerous cell line NIH‑3T3 and the human noncancerous fibroblast cell line VH10. The results suggested that Cu (II) complexes exhibit cytotoxic effects against the HT‑29 cell line, while complexes 3 and 4 were the most effective. Subsequent to 72 h of incubation, apoptosis was observed in the HT‑29 cells induced by Cu (II) complexes 1 (0.1, 1, 10 and 50 µmol/l), 2 (1, 10, 50 and 100 µmol/l), 3 (0.01, 1, 10 and 50 µmol/l) and 4 (0.01, 0.1, 1 and 10 µmol/l). The apoptotic pathways activated by the Cu (II) complexes were identified. The results indicated that complexes 2, 3 and 4 were able to induce the mitochondria‑dependent pathway of apoptosis in HT‑29 cells, while complex 1 was obsered to activate the extrinsic pathway of apoptosis. The levels of the anti‑apoptotic protein Bcl‑2 were reduced and those of the pro‑apoptotic protein Bax increased following treatment with complexes 2, 3 and 4. Complex 1 had no effect on Bax protein expression. Complexes 2 and 3 induced elevation of cytochrome c (cyt c), while complex 4 induced a time‑dependent elevation of cyt c levels. No cyt c was detected in HT‑29 cells exposed to complex 1, suggesting that Cu (II) complexes activated the extrinsic pathway of apoptosis. The results from the current study in addition to previous studies suggest that Schiff base Cu (II) complexes have potential as novel anticancer drugs.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x aplikace a dávkování $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a nádory tračníku $x farmakoterapie $x patologie $7 D003110
- 650 _2
- $a měď $x aplikace a dávkování $7 D003300
- 650 _2
- $a regulace genové exprese u nádorů $x účinky léků $7 D015972
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mitochondrie $x účinky léků $7 D008928
- 650 _2
- $a nádorové proteiny $x biosyntéza $7 D009363
- 650 _2
- $a Schiffovy báze $x aplikace a dávkování $7 D012545
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Perdikaris, Georgios A $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovak Republic.
- 700 1_
- $a Gbelcova, Helena $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovak Republic.
- 700 1_
- $a Andrezálová, Lucia $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovak Republic. $7 gn_A_00006628
- 700 1_
- $a Švéda, Martin $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Faculty of Food Biochemical Technology, 166 28 Prague, Czech Republic.
- 700 1_
- $a Ruml, Tomáš $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Faculty of Food Biochemical Technology, 166 28 Prague, Czech Republic.
- 700 1_
- $a Laubertová, Lucia $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovak Republic.
- 700 1_
- $a Žitňanová, Ingrid $u Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, 813 72 Bratislava, Slovak Republic.
- 773 0_
- $w MED00181650 $t Molecular medicine reports $x 1791-3004 $g Roč. 14, č. 5 (2016), s. 4436-4444
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27633628 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170908105250 $b ABA008
- 999 __
- $a ok $b bmc $g 1239266 $s 984498
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 14 $c 5 $d 4436-4444 $e 20160914 $i 1791-3004 $m Molecular medicine reports $n Mol Med Rep $x MED00181650
- LZP __
- $a Pubmed-20170720